ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.13
-0.32 (-1.26%)
At close: Aug 13, 2025, 4:00 PM
25.01
-0.12 (-0.48%)
After-hours: Aug 13, 2025, 6:35 PM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2024, ACADIA Pharmaceuticals had 654 total employees, including 653 full-time and 1 part-time employees. The number of employees increased by 56 or 9.36% compared to the previous year.
Employees
654
Change (1Y)
56
Growth (1Y)
9.36%
Revenue / Employee
$1,557,928
Profits / Employee
$339,694
Market Cap
4.24B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACAD News
- 2 days ago - Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 days ago - ACADIA Pharmaceuticals Inc. (ACAD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Acadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview - Business Wire
- 8 days ago - Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 9 days ago - Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer - Business Wire
- 16 days ago - Acadia Pharmaceuticals: ACP-101 Read-Out Is Not Fully Priced In - Seeking Alpha
- 21 days ago - Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2025 - Business Wire
- 7 weeks ago - Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers - Business Wire